Panion & Bf Biotech Inc. (TPE:1760)

Panion & Bf Biotech Revenue

Panion & Bf Biotech had revenue of 519.29M TWD in the quarter ending March 31, 2026, with 7.84% growth. This brings the company's revenue in the last twelve months to 2.10B, up 4.45% year-over-year. In the year 2025, Panion & Bf Biotech had annual revenue of 2.06B with 1.66% growth.

• Revenue (ttm): 2.10B
• Revenue Growth: +4.45%
• P/S Ratio: 2.46
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.06B	33.75M	1.66%
Dec 31, 2024	2.03B	147.77M	7.85%
Dec 31, 2023	1.88B	-516.77M	-21.54%
Dec 31, 2022	2.40B	497.44M	26.16%
Dec 31, 2021	1.90B	332.57M	21.20%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error